Weight Management

The global use of GLP-1 and GIP receptor agonists has significantly increased, driven by their effectiveness in managing type 2 diabetes and supporting weight loss. This class of medications includes popular injectable options like semaglutide and tirzepatide. Due to high demand, these medications have been added to the FDA’s Drug Shortage List. In response, the FDA has provided guidance for compounding pharmacies to produce essential alternatives while these drugs remain on the shortage list.

At Seven Lakes Prescription Shoppe, we have a relationship with a 503B compounding pharmacy that enables us to offer a compounded injectable semaglutide. A 503B pharmacy is a pharmacy that compounds in large volumes and is inspected and approved by the FDA. We wanted to make sure the product we are offering our patients is one that we could trust, so you could trust it too! Each batch received comes with a Certificate of Analysis showing the chemical composistion of the active ingredient. It also comes with potency and sterility testing from an independent lab. This shows that what you are prescribed is what you are injecting. Safety and accuracy are critical to us.